535 Results
Sort By:
Published on July 18, 2016
North Dakota-based Sanford Health, one of the country’s largest integrated health networks with 43 hospitals and nearly 250 clinics located in nine states, has tapped Translational Software Inc. (TSI) for its pharmacogenomics data and knowledge base, as it looks to significantly expand the system’s genomics program to multiple regions. TSI,…
Published on June 1, 2016
Sitting still inside a quiet room, in complete silence, place your hands over your ears. Focus on your breathing. Inhale, exhale, and repeat. Soon enough you will begin to feel the rhythmic beating of one of the most active muscles, undoubtedly the most critical, in the human body. Grab a…
Published on May 24, 2016
Identifying the genetic backgrounds that provide innate protection to maladies such as cancer, infectious diseases, or cardiovascular disorders is paramount to developing appropriate therapies to treat the majority of afflicted patients who suffer from these ailments. Now, an international team of researchers has focused their attention on elucidating the complex…
Published on March 14, 2016
Thousands of genetic variants have been associated with different diseases, but these variants still retain their most treacherous secrets—the mechanisms by which they contribute to disease processes. The trick is these mechanisms typically involve multiple conspirators—not just genes, but also transcription factors, enhancers, and promoters. If these networks could be…
Published on December 4, 2015
An NIH-funded study led by scientists at Harvard Medical School that were part of the Pediatric Cardiovascular Genetics Consortium have found a link for a set of gene mutations in the development of congenital heart disease and various neurodevelopmental abnormalities in children—include cognitive, motor, social, and language impairments. “We're homing…
Published on October 29, 2015
In many ways type 2 diabetes can be compared to cancer, in that it is a multifactorial disease that rarely affects each person similarly. For decades, the medical community has struggled to diagnose and treat type 2 diabetes since it presents with such a vast array of symptoms and associated…
Published on October 6, 2015
When Lorraine Potocki, M.D., attended medical school in the 1980s she didn’t have exposure to a genetics class. Dr. Potocki, a professor at Houston, TX-based Baylor College of Medicine’s department of Molecular and Human Genetics, wasn’t even aware that there were training programs in genetics until her residency was well…
Published on September 11, 2015
True Health Diagnostics agreed to pay $37.1 million to acquire Health Diagnostic Laboratory (HDL) after emerging as the successful bidder at a U.S. Bankruptcy Court auction, HDL said today. The sale is subject to final approval by Judge Kevin R. Huennekens of the U.S. Bankruptcy Court for the Eastern District…
Published on May 13, 2015
The Montreal Heart Institute (MHI) agreed to collaborate with AstraZeneca to search the genomes of up to 80,000 patients for genes associated with cardiovascular diseases and diabetes, their complications, and treatment outcomes. The goal is to drive understanding of the biologic mechanisms underlying these conditions and their complications and to…
Published on March 26, 2015
Ten biopharma companies have joined together to create the Genomics Expert Network for Enterprises (GENE) Consortium, which will oversee a year-long trial designed to integrate industry expertise into the 100,000 Genomes Project—the U.K.’s effort to catapult itself to global leadership in genetic research into cancer and rare diseases. Through the…